Danny Liew
#143,840
Most Influential Person Now
Researcher
Danny Liew's AcademicInfluence.com Rankings
Danny Liewcomputer-science Degrees
Computer Science
#7072
World Rank
#7449
Historical Rank
Algorithms
#263
World Rank
#266
Historical Rank
Computational Linguistics
#1347
World Rank
#1362
Historical Rank
Machine Learning
#2498
World Rank
#2531
Historical Rank
Download Badge
Computer Science
Danny Liew's Degrees
- Bachelors Computer Science University of California, Berkeley
- Masters Artificial Intelligence Stanford University
Similar Degrees You Can Earn
Why Is Danny Liew Influential?
(Suggest an Edit or Addition)Danny Liew's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study (2017) (659)
- Crohn's disease management after intestinal resection: a randomised trial (2015) (436)
- Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. (2005) (313)
- Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis (2020) (290)
- Emergency department length of stay independently predicts excess inpatient length of stay (2003) (252)
- Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. (2015) (241)
- Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis (2021) (226)
- Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults (2019) (209)
- The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis. (2009) (166)
- The impact of pre-operative obesity on weight change and outcome in total knee replacement: a prospective study of 529 consecutive patients. (2010) (153)
- Clozapine-Associated Myocarditis (2007) (146)
- Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. (2014) (145)
- Fingolimod after natalizumab and the risk of short-term relapse (2014) (143)
- Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. (2013) (135)
- Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long‐term Intervention with Pravastatin in Ischaemic Disease (LIPID) study (2003) (123)
- Interventions to reduce medication errors in adult intensive care: a systematic review. (2012) (121)
- Lifetime risk and projected population prevalence of diabetes (2008) (108)
- Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients (2013) (108)
- Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. (2013) (107)
- Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis (2015) (102)
- Cost analysis of debridement and retention for management of prosthetic joint infection. (2013) (99)
- Clozapine‐induced cardiotoxicity: a clinical update (2009) (92)
- Effectiveness of general practice based, practice nurse led telephone coaching on glycaemic control of type 2 diabetes: the Patient Engagement And Coaching for Health (PEACH) pragmatic cluster randomised controlled trial (2013) (90)
- N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study (2012) (90)
- Cost-Benefit of Minimally Invasive Staging of Non-small Cell Lung Cancer: A Decision Tree Sensitivity Analysis (2010) (90)
- Recent Patterns of Multimorbidity Among Older Adults in High-Income Countries. (2019) (88)
- Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis (2009) (88)
- Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions (2014) (83)
- A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer. (2018) (80)
- The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model (2012) (76)
- Risk of relapse phenotype recurrence in multiple sclerosis (2014) (72)
- A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia. (2013) (71)
- Pyoderma gangrenosum requiring inpatient management: A report of 26 cases with follow up (2011) (71)
- Characterising risk of in-hospital mortality following cardiac arrest using machine learning: A retrospective international registry study (2018) (70)
- Subtrochanteric fracture: the effect of cerclage wire on fracture reduction and outcome. (2015) (70)
- The impact of obesity on weight change and outcomes at 12 months in patients undergoing total hip arthroplasty (2010) (65)
- Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors (2009) (64)
- Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis (2019) (60)
- Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged ≥70 (2005) (59)
- Economic burden of obesity in primary total knee arthroplasty (2011) (58)
- Potential survival gains in the treatment of myocardial infarction (2009) (58)
- Attitudes towards antimicrobial stewardship: results from a large private hospital in Australia (2014) (56)
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial (2017) (55)
- The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study (2013) (55)
- Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysis (2018) (54)
- The cost‐benefit of using soft silicone multilayered foam dressings to prevent sacral and heel pressure ulcers in trauma and critically ill patients: a within‐trial analysis of the Border Trial (2015) (54)
- Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service. (2015) (53)
- Projected Burden of Osteoarthritis and Rheumatoid Arthritis in Australia: A Population‐Level Analysis (2018) (53)
- Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation (2017) (52)
- Current and emerging antiviral treatments for hepatitis C infection (2013) (52)
- A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years (2018) (51)
- Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit. (2016) (50)
- Poorer outcomes and greater healthcare costs for hospitalised older people with dementia and delirium: a retrospective cohort study (2017) (48)
- Rethinking pandemic preparation: Global Health Security Index (GHSI) is predictive of COVID-19 burden, but in the opposite direction (2020) (48)
- Comparison of Health-Related Quality of Life, Work Status, and Health Care Utilization and Costs According to Hip and Knee Joint Disease Severity: A National Australian Study (2013) (48)
- The Role of Traditional Cardiovascular Risk Factors Among Patients with Rheumatoid Arthritis (2008) (47)
- Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. (2020) (47)
- Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review (2017) (46)
- Cardiac fibrosis in the ageing heart: Contributors and mechanisms (2017) (46)
- Accuracy of national mortality codes in identifying adjudicated cardiovascular deaths (2011) (45)
- Clinical effectiveness of a silicone foam dressing for the prevention of heel pressure ulcers in critically ill patients: Border II Trial. (2015) (45)
- Systematic review with meta‐analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel (2018) (45)
- A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin. (2007) (45)
- Productivity Burden of Hypertension in Australia: A Life Table Modeling Study (2019) (45)
- Excess mortality and hospitalized morbidity in newly treated epilepsy patients (2016) (45)
- The Productivity Burden of Diabetes at a Population Level (2018) (44)
- Overview of methods for comparing the efficacies of drugs in the absence of head‐to‐head clinical trial data (2014) (44)
- Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study (2011) (44)
- The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-up. (2009) (43)
- The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform (2013) (41)
- Impact of scribes on emergency medicine doctors’ productivity and patient throughput: multicentre randomised trial (2019) (40)
- Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort (2018) (40)
- Predictors of disability worsening in clinically isolated syndrome (2015) (40)
- Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute Stroke (2018) (40)
- Hepatic macrophage activation predicts clinical decompensation in chronic liver disease (2013) (40)
- Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the ‘old’ versus the ‘new’ Framingham equation (2011) (39)
- The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice (2016) (39)
- Identification of urinary biomarkers for age-related macular degeneration. (2011) (38)
- Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases (2015) (37)
- The association between radiographic severity and pre-operative function in patients undergoing primary knee replacement for osteoarthritis. (2012) (37)
- Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke: Experience From Australian Stroke Center (2013) (37)
- Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis (2020) (37)
- Cardiorenal syndrome: Multi‐organ dysfunction involving the heart, kidney and vasculature (2020) (36)
- A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005 - 2016 (2019) (35)
- Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies (2018) (35)
- The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis. (2020) (34)
- Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations. (2012) (34)
- Clearing emergency departments and clogging wards: National Emergency Access Target and the law of unintended consequences (2014) (34)
- Controlled clinical trial of a self-management program for people with mental illness in an adult mental health service - the Optimal Health Program (OHP). (2012) (34)
- Overview of pharmacoeconomic modelling methods (2013) (34)
- Pharmacists’ Interprofessional Communication About Medications in Specialty Hospital Settings (2015) (34)
- Radial probe EBUS versus CT-guided needle biopsy for evaluation of peripheral pulmonary lesions: an economic analysis (2012) (33)
- Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment (2016) (32)
- Patterns of statin use and long‐term adherence and persistence among older adults with diabetes (2018) (32)
- Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis. (2011) (32)
- Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience (2013) (32)
- Productivity burden of smoking in Australia: a life table modelling study (2018) (31)
- Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome (2017) (31)
- Forecasting the future burden of opioids for osteoarthritis. (2017) (31)
- Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study (2013) (31)
- Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study (2020) (31)
- An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study. (2014) (31)
- Resting heart rate, temporal changes in resting heart rate, and overall and cause-specific mortality (2017) (31)
- The impact of diabetes on productivity in China (2019) (30)
- Effect of intestinal resection on quality of life in Crohn's disease. (2015) (29)
- Using periodic point‐prevalence surveys to assess appropriateness of antimicrobial prescribing in Australian private hospitals (2014) (28)
- Skipping Breakfast and the Risk of Cardiovascular Disease and Death: A Systematic Review of Prospective Cohort Studies in Primary Prevention Settings (2019) (28)
- Working with CALD groups: testing the feasibility of an intervention to improve medication self- management in people with kidney disease, diabetes, and cardiovascular disease (2012) (28)
- Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure (2005) (28)
- Natural Regression of Frailty Among Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. (2019) (28)
- A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia. (2015) (28)
- Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma (2016) (27)
- Vitamin D in newborns. A randomised controlled trial comparing daily and single oral bolus vitamin D in infants (2017) (27)
- Implementing antimicrobial stewardship in the Australian private hospital system: a qualitative study. (2015) (27)
- Cardiovascular effects of selective cyclooxygenase-2 inhibitors (2004) (27)
- Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia. (2010) (27)
- Moving From Heart Failure Guidelines to Clinical Practice: Gaps Contributing to Readmissions in Patients With Multiple Comorbidities and Older Age (2018) (27)
- Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. (2020) (26)
- Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia. (2008) (26)
- Real‐world outcomes of unrestricted direct‐acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience (2018) (26)
- Using technology to support care in gestational diabetes mellitus: Quantitative outcomes of an exploratory randomised control trial of adjunct telemedicine for gestational diabetes mellitus (TeleGDM). (2018) (26)
- An economic evaluation of the costs of training a medical scribe to work in Emergency Medicine (2016) (26)
- Do statin users adhere to a healthy diet and lifestyle? The Australian Diabetes, Obesity and Lifestyle Study (2017) (26)
- Predictors of first‐year nonadherence and discontinuation of statins among older adults: a retrospective cohort study (2018) (25)
- Effects of patient-, environment- and medication-related factors on high-alert medication incidents. (2014) (25)
- N‐terminal B‐type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluation of the Evolution of New‐Heart Failure Study (SCREEN‐HF) (2013) (25)
- Barriers and enablers affecting patient engagement in managing medications within specialty hospital settings (2015) (25)
- Drug‐induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients (2014) (24)
- The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective. (2018) (24)
- 925j Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study. (2013) (24)
- Injury trends from envenoming in Australia, 2000–2013 (2017) (24)
- Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long‐Term Risk for Fragility Fracture: A Prospective Study (2019) (23)
- A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data (2018) (23)
- Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment? (2020) (22)
- Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA) (2018) (22)
- OP023 Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study (2014) (22)
- Substitution Monotherapy With Levetiracetam vs Older Antiepileptic Drugs: A Randomized Comparative Trial. (2012) (22)
- The role of dihydrosphingolipids in disease (2018) (22)
- Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions. (2009) (21)
- Cost of gastroenteritis in Australia: A healthcare perspective (2018) (21)
- The costs of epilepsy in Australia (2020) (21)
- Comparison of Fecal Inflammatory Markers in Crohn's Disease (2016) (21)
- Observational studies and their utility for practice. (2018) (21)
- Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia. (2009) (21)
- The economic implications of treating atherothrombotic disease in Australia, from the government perspective. (2010) (21)
- The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study (2020) (21)
- Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective. (2018) (21)
- Caring for people with dementia in hospital: findings from a survey to identify barriers and facilitators to implementing best practice dementia care (2016) (21)
- 1161 Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study (2012) (21)
- Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn’s Disease (2018) (20)
- Quantifying the excess cost and resource utilisation for patients with complications associated with elective knee arthroscopy: a retrospective cohort study. (2014) (20)
- Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis (2020) (20)
- The “cost” of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice (2013) (20)
- Performance of the Assessment of Quality of Life Measure in People With Hip and Knee Joint Disease and Implications for Research and Clinical Use (2014) (20)
- Blood Pressure Effects of COX-2 Inhibitors (2006) (19)
- A Model for Predicting the Future Incidence of Coronary Heart Disease Within Percentiles of Coronary Heart Disease Risk (2001) (19)
- Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes (2013) (19)
- Cohort Profile: The Hazelwood Health Study Adult Cohort. (2020) (19)
- Cost‐effectiveness of prescribing statins according to Pharmaceutical Benefits Scheme criteria (2001) (19)
- The impact of diabetes on the productivity and economy of Bangladesh (2020) (19)
- Serologic antibodies in relation to outcome in postoperative Crohn's disease (2017) (19)
- Should patients with chronic heart failure be treated with "statins"? (2003) (19)
- Cost-effectiveness of 12-month treatment with ticagrelor compared with clopidogrel in the management of acute coronary syndromes. (2013) (19)
- Current status of endothelin blockade for the treatment of cardiovascular and pulmonary vascular disease. (2003) (19)
- Dr Foster global frailty score: an international retrospective observational study developing and validating a risk prediction model for hospitalised older persons from administrative data sets (2019) (18)
- Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea. (2009) (18)
- Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario (2018) (18)
- Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia (2015) (18)
- Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions (2014) (18)
- Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness (2020) (18)
- The cost-effectiveness of hospital-based telephone coaching for people with type 2 diabetes: a 10 year modelling analysis (2016) (18)
- Switching, Discontinuation, and Reinitiation of Statins Among Older Adults. (2018) (18)
- Prediction of incident heart failure by serum amino‐terminal pro‐B‐type natriuretic peptide level in a community‐based cohort (2019) (18)
- Threshold body mass index and sex-specific waist circumference for increased risk of heart failure with preserved ejection fraction (2019) (18)
- Impact of tobacco use on health and work productivity in Malaysia (2019) (17)
- Implementing a national first-line management program for moderate-severe knee osteoarthritis in Australia: A budget impact analysis focusing on knee replacement avoidance (2020) (17)
- Incidence of fatal snake bite in Australia: A coronial based retrospective study (2000–2016) (2017) (17)
- The role of aldosterone receptor blockade in the management of cardiovascular disease. (2002) (17)
- Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective (2018) (17)
- Medication communication during handover interactions in specialty practice settings. (2015) (17)
- Benefits and resource implications of family meetings for hospitalized palliative care patients: research protocol (2015) (17)
- Drug treatment and cost of cardiovascular disease in Australia. (2009) (17)
- Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol (2014) (17)
- Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population. (2019) (17)
- Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective. (2020) (17)
- Criteria for Identifying Patients With Staphylococcus aureus Bacteremia Who Are at Low Risk of Endocarditis: A Systematic Review (2017) (16)
- Economic evaluation of clinical quality registries: a systematic review (2019) (16)
- Effect of Bariatric Surgery on Risk of Complications After Total Knee Arthroplasty (2022) (16)
- Counting the cost. Part 1 Healthcare costs: The current and future burden of arthritis (2016) (16)
- Circulating CD147 predicts mortality in advanced hepatocellular carcinoma (2016) (16)
- Additional structured physical activity does not improve walking in older people (>60years) undergoing inpatient rehabilitation: a randomised trial. (2018) (16)
- Clinicians’ adherence to international guidelines in the clinical care of adults with inflammatory bowel disease (2017) (16)
- Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms (2014) (16)
- Histidine‐containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta‐analysis of randomized controlled trials (2019) (16)
- Inclisiran as Adjunct Lipid-Lowering Therapy for Patients with Cardiovascular Disease: A Cost-Effectiveness Analysis (2020) (16)
- A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease (2006) (16)
- Novel Biomedical Risk Markers for Cardiovascular Disease (2003) (16)
- Diabetes Prevention and Treatment Strategies (2013) (15)
- Phase 4 Studies in Heart Failure - What is Done and What is Needed? (2016) (15)
- Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study (2020) (15)
- Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease (2010) (15)
- Adalimumab prevents post-operative Crohn's disease recurrence, and is superior to thiopurines: early results from the POCER study (2012) (15)
- Overview of shorthand medical glossary (OMG ) study (2015) (14)
- Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes (2019) (14)
- Coronary artery calcium scoring in cardiovascular risk assessment of people with family histories of early onset coronary artery disease. (2020) (14)
- Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma (2019) (14)
- Educating junior doctors and pharmacists to reduce discharge prescribing of opioids for surgical patients: a cluster randomised controlled trial (2020) (14)
- Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome. (2019) (14)
- Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden (2021) (13)
- Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma. (2016) (13)
- Using WOMAC Index scores and personal characteristics to estimate Assessment of Quality of Life utility scores in people with hip and knee joint disease (2014) (13)
- Health Technology Assessment Challenges in Oncology: 20 Years of Value in Health. (2019) (13)
- Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy (2020) (13)
- Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol (2016) (13)
- The ‘four‐hour target’ and the impact on Australian metropolitan acute surgical services (2016) (13)
- Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes (2018) (13)
- Chronic pain medication management of older populations: Key points from a national conference and innovative opportunities for pharmacy practice (2019) (13)
- Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis (2012) (12)
- A randomized controlled trial of physical activity with individual goal-setting and volunteer mentors to overcome sedentary lifestyle in older adults at risk of cognitive decline: the INDIGO trial protocol (2017) (12)
- Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis. (2020) (12)
- NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF). (2013) (12)
- Do Patients Who Take Part in Stroke Research Differ from Non-Participants? Implications for Generalizability of Results (2013) (12)
- Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy. (2019) (12)
- Evaluating the effects of increasing physical activity to optimize rehabilitation outcomes in hospitalized older adults (MOVE Trial): study protocol for a randomized controlled trial (2015) (12)
- The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction. (2021) (12)
- New and emerging drug therapies for the management of acute heart failure (2003) (12)
- Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort. (2013) (11)
- Real-world adherence, persistence, and in-class switching during use of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis involving 594,138 patients with type 2 diabetes (2020) (11)
- Age‐related longitudinal change in cardiac structure and function in adults at increased cardiovascular risk (2020) (11)
- Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review (2018) (11)
- Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective (2016) (11)
- Cost Effectiveness of Eplerenone in Patients with Chronic Heart Failure (2014) (11)
- Cost-effectiveness analysis of a hybrid closed-loop system versus multiple daily injections and capillary glucose testing for adults with type 1 diabetes. (2020) (11)
- Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis. (2019) (11)
- Predicting blood loss and transfusion requirement in patients undergoing surgery for musculoskeletal tumors (2012) (11)
- Attenuating PI3K/Akt- mTOR pathway reduces dihydrosphingosine 1 phosphate mediated collagen synthesis and hypertrophy in primary cardiac cells. (2021) (11)
- Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia (2018) (11)
- Outcomes of decompressive craniectomy in patients after traumatic brain injury. (2015) (11)
- Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective. (2021) (10)
- The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective. (2019) (10)
- A Markov cost‐effective analysis of biannual fluoride varnish for preventing dental caries in permanent teeth over a 70‐year time horizon (2019) (10)
- Association of Spicy Chilli Food Consumption With Cardiovascular and All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies (2021) (10)
- Impact of emergency access targets on admissions to general medicine: a retrospective cohort study (2013) (10)
- Cost-effectiveness of Crohn's disease post-operative care. (2016) (10)
- Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand (2019) (10)
- Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis (2020) (10)
- Clinical decision support improves quality of care in patients with ulcerative colitis (2019) (10)
- Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective. (2019) (10)
- An open-label, non-inferiority randomized controlled trial of lidocAine Versus Opioids In MyocarDial Infarction study (AVOID-2 study) methods paper. (2021) (10)
- What risk of endocarditis is low enough to justify the omission of transoesophageal echocardiography in Staphylococcus aureus bacteraemia? A narrative review. (2018) (10)
- Long Term Outcome of Multidisciplinary versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders. A Randomised Trial. (2021) (10)
- Economic evaluation of micafungin vs. Liposomal Amphotericin B (LAmB) for the treatment of candidaemia and Invasive Candidiasis (IC) (2013) (10)
- Health and productivity burden of coronary heart disease in the working Indonesian population using life-table modelling (2020) (10)
- Reinitiation of Statin Therapy After Discontinuation: A Meta‐analysis (2018) (10)
- Exogenous dihydrosphingosine 1 phosphate mediates collagen synthesis in cardiac fibroblasts through JAK/STAT signalling and regulation of TIMP1. (2020) (10)
- The future burden of vision loss in Australia: projections from the National Eye Health Survey. (2020) (10)
- Evaluating antimicrobial therapy: How reliable are remote assessors? (2016) (10)
- New developments in the pharmacological treatment of chronic heart failure (2003) (10)
- An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocol (2014) (10)
- Is a biomarker‐based diagnostic strategy for invasive aspergillosis cost effective in high‐risk haematology patients? (2017) (9)
- Cost-effectiveness of optimizing use of statins in Australia: using outpatient data from the REACH Registry. (2011) (9)
- Impact of Limited English Proficiency on Presentation and Clinical Outcomes of Patients Undergoing Primary Percutaneous Coronary Intervention. (2019) (9)
- Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis. (2020) (9)
- Are Lifestyle Interventions to Reduce Excessive Gestational Weight Gain Cost Effective? A Systematic Review (2020) (9)
- Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands (2012) (9)
- Benefit of Echocardiography in Patients With Staphylococcus aureus Bacteremia at Low Risk of Endocarditis (2018) (9)
- First-line Treatment with Empagliflozin and Metformin Combination Versus Standard Care for Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease in Qatar. A Cost-Effectiveness Analysis. (2021) (9)
- Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers (2020) (9)
- Productivity Burden of Occupational Noise-Induced Hearing Loss in Australia: A Life Table Modelling Study (2020) (9)
- The effect of joint aspiration and corticosteroid injections in osteoarthritis of the knee (2011) (9)
- Benefit of targeted, pharmacist‐led education for junior doctors in reducing prescription writing errors – a controlled trial (2018) (9)
- Risk factor management in a contemporary Australian population at increased cardiovascular disease risk (2018) (9)
- A prospective study of the incidence of drug‐induced liver injury by the modern volatile anaesthetics sevoflurane and desflurane (2019) (9)
- Characteristics of national and major regional percutaneous coronary intervention registries: a structured literature review. (2018) (9)
- Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn ' s Disease Following Surgery (2015) (9)
- Do family meetings for hospitalised palliative care patients improve outcomes and reduce health care costs? A cluster randomised trial (2020) (8)
- Blood pressure and risk of breast cancer, overall and by subtypes: a prospective cohort study (2017) (8)
- Projecting the Incidence of Type 2 Diabetes–Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes Treatment (2021) (8)
- Prevalence, Outcomes and Cost Implications of Patients Undergoing Same Day Discharge After Elective Percutaneous Coronary Intervention in Australia. (2019) (8)
- Incidence, Predictors and Clinical Outcomes of Stent Thrombosis Following Percutaneous Coronary Intervention in Contemporary Practice. (2019) (8)
- Poor adherence and persistence to sodium glucose co‐transporter 2 inhibitors in real‐world settings: Evidence from a systematic review and meta‐analysis (2020) (8)
- The economic impact of sudden cardiac arrest. (2021) (8)
- The impact of preoperative obesity on weight change and outcome in total knee replacement: A prospective study of 529 consecutive patients (Journal of Bone and Joint Surgery (Br) (2010) 92-B, (513-520)) (2010) (8)
- Outcomes and excess costs among patients with cardiovascular disease. (2013) (8)
- The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era. (2019) (8)
- GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice (2018) (8)
- Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation (2021) (8)
- The functions and roles of questioning during nursing handovers in specialty settings: an ethnographic study (2017) (8)
- The cardiovascular safety of celecoxib. (2005) (8)
- Predicting the Impact of Polypill Use in a Metabolic Syndrome Population: An Effectiveness and Cost-Effectiveness Analysis (2013) (8)
- Incidence and Predictors of Unplanned Hospital Readmission after Percutaneous Coronary Intervention (2020) (8)
- LDL‐Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk (2018) (8)
- Cost Burden and Cost-Effective Analysis of the Nationwide Implementation of the Quality in Acute Stroke Care Protocol in Australia. (2021) (7)
- The Frequency of, and Factors Associated with Prolonged Hospitalization: A Multicentre Study in Victoria, Australia (2020) (7)
- Changes to the statin prescribing policy in Belgium: potential impact in clinical and economic terms. (2012) (7)
- Epidemiological modelling (including economic modelling) and its role in preventive drug therapy (2002) (7)
- Predictors of statin use among older adults: A nationwide cross-sectional study. (2019) (7)
- First seizure presentations in adults: beyond assessment and treatment (2019) (7)
- The Health and Productivity Burden of Depression in South Korea (2021) (7)
- Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia (2012) (7)
- National nursing registration in Australia: A way forward for nurse practitioner endorsement (2012) (7)
- National Heart Foundation of Australia: position statement on coronary artery calcium scoring for the primary prevention of cardiovascular disease in Australia (2021) (7)
- A feeling in the waters: diagnosis of heart failure using urinary natriuretic peptides. (2004) (7)
- A Scenario-Based Survey of Expert Echocardiography Recommendations for Patients With Staphylococcus aureus Bacteremia at Varying Risk for Endocarditis (2020) (7)
- Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial (2020) (7)
- Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029. (2021) (7)
- Early signs that COVID-19 is being contained in Australia (2020) (7)
- COST-EFFECTIVENESS OF RENAL DENERVATION THERAPY FOR TREATMENT RESISTANT HYPERTENSION: A BEST CASE SCENARIO (2018) (7)
- Burden of disease and productivity impact of Streptococcus suis infection in Thailand. (2021) (7)
- Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency? (2019) (7)
- Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels? (2006) (7)
- Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents. (2019) (7)
- A population‐based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state‐wide registry and costing databases: 2009‐2015 (2019) (7)
- Endoscopic Prediction of Crohn's Disease Postoperative Recurrence. (2021) (7)
- Hazelwood Health Study Adult Survey: Volume 1 Comparison of Morwell and Sale (2017) (7)
- Safety and efficacy of the BCL2 inhibitor venetoclax in estrogen receptor (ER) and BCL2-positive metastatic breast cancer: The mBEP study. (2017) (7)
- Utility of B-type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetes: response to Epshteyn et al. (2004) (7)
- Efficacy of interpersonal psychotherapy for post-traumatic stress disorder: A systematic review and meta-analysis. (2020) (7)
- Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data (2021) (7)
- SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace. (2017) (7)
- Moderate or severe low back pain is associated with body mass index amongst community-dwelling older Australians. (2020) (6)
- Predicting the Effectiveness of Prevention: A Role for Epidemiological Modeling (2008) (6)
- The economic impact of familial hypercholesterolemia on productivity. (2020) (6)
- Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis (2013) (6)
- Carnosine and histidine-containing dipeptides improve dyslipidemia: a systematic review and meta-analysis of randomized controlled trials. (2020) (6)
- The Health and Productivity Burden of Migraines in Australia (2020) (6)
- Productivity Benefits of Preventing Type 2 Diabetes in Australia: A 10-Year Analysis (2021) (6)
- Is establishing a specialist back pain assessment and management service in primary care a safe and effective model? Twelve-month results from the Back pain Assessment Clinic (BAC) prospective cohort pilot study (2018) (6)
- Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study (2018) (6)
- Clinical predictors and prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: attention must be paid to the reference standard. (2017) (6)
- Cost-effectiveness of Radial Access Percutaneous Coronary Intervention in Acute Coronary Syndrome. (2021) (6)
- Effects of Statins for Secondary Prevention on Functioning and Other Outcomes Among Nursing Home Residents. (2020) (6)
- Su2092 Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study (2012) (6)
- Predictors of health care use among patients with or at high risk of atherothrombotic disease: two-year follow-up data. (2014) (6)
- The impact of coronary heart disease prevention on work productivity: a 10-year analysis. (2020) (6)
- Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study (2019) (6)
- Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review (2017) (6)
- The Volunteer Dementia and Delirium Care (VDDC)© program: An exploration of perceived barriers and enablers to implementation in an acute and subacute metropolitan hospital (2019) (6)
- Examination of the relationship between disease activity and patient‐reported outcome measures in an inflammatory bowel disease cohort (2018) (6)
- A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre. (2019) (5)
- Estimating the Productivity Burden of Pediatric Pneumococcal Disease in Thailand (2020) (5)
- Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review (2018) (5)
- An epidemiological study of paediatric adenotonsillectomy in Victoria, Australia, 2010‐2015: Changing indications and lack of effect of hospital volume on inter‐hospital transfers (2019) (5)
- Aldosterone receptor antagonists for hypertension: what do they offer? (2003) (5)
- Long‐term persistence and adherence to blood pressure lowering agents among older Australians (2019) (5)
- Risk-Adjusting Key Outcome Measures in a Clinical Quality PCI Registry: Development of a Highly Predictive Model Without the Need to Exclude High-Risk Conditions. (2019) (5)
- Changes to the Statin Prescribing Policy in Belgium (2012) (5)
- Clinical effectiveness of a silicone foam dressing for the prevention of heel pressure ulcers in critically ill patients: Border II Trial. (2020) (5)
- Adverse Drug Reactions Associated With Cholinesterase Inhibitors-Sequence Symmetry Analyses Using Prescription Claims Data. (2017) (5)
- Determining the cost of first-ever seizures: A narrative review and future directions (2019) (5)
- 844 Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis (2020) (5)
- Communicating with patients, families and health professionals about managing medications in intensive care: A qualitative observational study. (2019) (5)
- The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reduction. (2020) (5)
- Cost‐Minimisation Analysis of Midazolam versus Droperidol for Acute Agitation in the Emergency Department (2012) (5)
- Frailty Confers High Mortality Risk across Different Populations: Evidence from an Overview of Systematic Reviews and Meta-Analyses (2020) (5)
- An Economic Evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry Program (ANZACS-QI 28). (2020) (5)
- Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis. (2021) (5)
- Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate (2018) (5)
- P342 Adalimumab prevents post-operative Crohn's disease recurrence and is superior to thiopurines: E (2012) (4)
- 312 The First Validated Post-Operative Endoscopic Crohns Disease Index: The POCER Index. Identification of Key Endoscopic Prognostic Factors (2016) (4)
- Abstract PD1-06: A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2–positive metastatic breast cancer (MBC) (2019) (4)
- Patterns of Medication Dispensation for Multiple Comorbidities among Older Adults in Australia (2018) (4)
- Ambiguous medical abbreviation study: challenges and opportunities (2020) (4)
- Recommended Intake of Key Food Groups and Cardiovascular Risk Factors in Australian Older, Rural-Dwelling Adults (2020) (4)
- Su1318 Intestinal Resection in Crohn's Disease Is Associated With Significant and Durable Improvement in Health Related Quality of Life Although to a Lesser Extent in Women and Smokers. Results From the POCER Study (2014) (4)
- Attainment of low-density lipoprotein cholesterol goals in statin treated patients: real-world evidence from Australia (2021) (4)
- Clinical variation in the use of echocardiography in Staphylococcus aureus bacteraemia: a multi-centre cohort study (2018) (4)
- Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition. (2021) (4)
- The Preventable Productivity Burden of Kidney Disease in Australia. (2021) (4)
- Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis. (2021) (4)
- Comparisons of direct and indirect utilities in adult epilepsy populations: A systematic review (2019) (4)
- Aldosterone Receptor Antagonists for Hypertension (2012) (4)
- Impact of emergency medical service delays on time to reperfusion and mortality in STEMI (2021) (4)
- Estimating the economic impacts of percutaneous coronary intervention in Australia: a registry-based cost burden study (2021) (4)
- Health care costs associated with Australian tertiary inflammatory bowel disease care (2017) (4)
- Renal safety of short‐term empiric gentamicin therapy in aged patients (2018) (4)
- Clinical characteristics of people with heart failure in Australian general practice: results from a retrospective cohort study (2021) (4)
- Development and validation of a comprehensive early risk prediction model for patients with undifferentiated acute chest pain (2022) (4)
- Cost-Effectiveness of Empagliflozin and Metformin Combination Versus Standard Care as First-Line Therapy in Patients with Type 2 Diabetes Mellitus. (2021) (4)
- Economic implications of obesity among people with atherothrombotic disease (2010) (4)
- Applying a framework to assess the impact of cardiovascular outcomes improvement research (2021) (4)
- Age‐specific diastolic dysfunction improves prediction of symptomatic heart failure by Stage B heart failure (2019) (4)
- Early transthoracic echocardiography has useful prognostic value in left-sided native valve endocarditis despite limited diagnostic performance (2019) (4)
- Productivity burden of hypertension in Japan (2021) (4)
- Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma (2020) (4)
- Assessing the impact of smoking on the health and productivity of the working-age Indonesian population using modelling (2020) (4)
- Anti-VEGF Treatment on Human Tenons’ Fibroblasts Scarring Activity in vitro (2008) (4)
- Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol (2021) (4)
- Prescription of physical activity in the management of high blood pressure in Australian general practices (2018) (3)
- Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta-analysis of randomized controlled trials. (2020) (3)
- Mind the Gap: Mismatches Between Clinicians and Patients in Heart Failure Medication Management (2018) (3)
- A Comparison of Three Survival Models to Estimate The Cost-Effectiveness of Cancer Immunotherapy In The Treatment of Advanced Melanoma. (2015) (3)
- Sex differences in Cardiac electronic device implantation: Outcomes from an Australian multi-centre clinical quality registry (2021) (3)
- The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry. (2013) (3)
- A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus. (2022) (3)
- The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling" (2020) (3)
- RESPOND: a programme to prevent secondary falls in older people presenting to the emergency department with a fall: protocol for an economic evaluation (2016) (3)
- Trends in the Dispensing and Costs of Glucose-Lowering Medications Among Older Australians: Findings from National Claims Data (2020) (3)
- Kidney age - chronological age difference (KCD) score provides an age-adapted measure of kidney function (2021) (3)
- A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin‐based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels (2012) (3)
- Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis (2021) (3)
- Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve (2014) (3)
- The epidemiology of heart failure in the general Australian community - study of heart failure in the Australian primary carE setting (SHAPE): methods (2019) (3)
- Markers of Cardiovascular Disease among Adults Exposed to Smoke from the Hazelwood Coal Mine Fire (2021) (3)
- The Volunteer Dementia and Delirium Care (VDDC)©: A pre‐implementation study exploring perceived acceptability to implementing the program in an acute and subacute metropolitan hospital (2019) (3)
- Gazing through time and beyond the health sector: Insights from a system dynamics model of cardiovascular disease in Australia (2021) (3)
- Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis (2022) (3)
- The cost‐effectiveness of radial access percutaneous coronary intervention: A propensity‐score matched analysis of Victorian data (2022) (3)
- Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system (2021) (3)
- Eplerenone in the treatment of chronic heart failure (2004) (3)
- Trends in the Utilization of Lipid-Lowering Medications in Australia: An Analysis of National Pharmacy Claims Data. (2021) (3)
- Outcomes of community‐based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation (2020) (3)
- Epidemiology of heart failure: Study of Heart failure in the Australian Primary carE setting (SHAPE) (2020) (3)
- A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer (2018) (3)
- Sociodemographic associations of geographic variation in paediatric tonsillectomy and adenoidectomy (2021) (2)
- Risk factors for asymptomatic echocardiographic abnormalities that predict symptomatic heart failure (2021) (2)
- Does warfarin-related intracerebral haemorrhage lead to higher costs of management? (2014) (2)
- A Randomized Controlled Trial on the Effects of a 6-Month Home-Based Physical Activity Program with Individual Goal-Setting and Volunteer Mentors on Physical Activity, Adherence, and Physical Fitness in Inactive Older Adults at Risk of Cognitive Decline: The INDIGO Study. (2021) (2)
- Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction (2022) (2)
- The Challenges of Stem Cell Therapy in Myocardial Infarction and Heart Failure and the Potential Strategies to Improve the Outcomes (2018) (2)
- Relation of Timing of Percutaneous Coronary Intervention on Outcomes in Patients with Non-ST Segment Elevation Myocardial Infarction. (2020) (2)
- Population genomic screening of all young adults in Australia to detect familial hypercholesterolemia: a cost-effectiveness analysis (2021) (2)
- Prediction of disability-free survival in healthy older people (2022) (2)
- Predictors of annual pharmaceutical costs in Australia for participants with or at risk of cardiovascular disease : analysis of Australian data from the REACH Registry (2010) (2)
- 998 Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the POCER Study (2014) (2)
- Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation (2022) (2)
- Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective (2020) (2)
- A Cost Effectiveness Analysis of Nivolumab Compared to Ipilimumab for the Treatment of Braf Wild-Type Advanced Melanoma in Australia. (2015) (2)
- Hospital revisits after paediatric tonsillectomy: a cohort study (2022) (2)
- Metal stents are safe and cost‐effective for preoperative biliary drainage in resectable pancreaticobiliary tumours (2021) (2)
- PIN65 ESTIMATING THE LIFETIME ECONOMIC BURDEN OF STREPTOCOCCUS SUIS AND ITS PRODUCTIVITY IMPACT IN THAILAND (2020) (2)
- Factors associated with improved walking in older people during hospital rehabilitation: secondary analysis of a randomized controlled trial (2021) (2)
- Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016 (2018) (2)
- Abstract 4429: Do COX-2 Inhibitors Raise Blood Pressure More Than Non-selective NSAIDs and Placebo?: An Updated Meta-analysis of Clinical Trials Involving >130,000 Participants (2008) (2)
- Cost-minimisation analysis of midazolam versus droperidol in the management of acute agitation in the emergency department (2012) (2)
- 597 Serological Antibodies for the Prediction of Post-Operative Recurrent Crohn's Disease Results From the POCER Study (2015) (2)
- Correction: Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis (2019) (2)
- The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate. (2021) (2)
- Characteristics and outcomes of unsuccessful percutaneous coronary intervention (2021) (2)
- DOP064 Faecal calprotectin is superior to faecal lactoferrin and S100A12 (2014) (2)
- The Impact of Diabetes on Productivity in India (2021) (2)
- Angiotensin receptor neprilysin inhibitor LCZ696: pharmacology, pharmacokinetics and clinical development. (2017) (2)
- A home-based, multidisciplinary liver optimisation programme for the first 28 days after an admission for acute-on-chronic liver failure (LivR well): a study protocol for a randomised controlled trial (2022) (2)
- Difficulties in Recruitment for a Randomised Controlled Trial of Lifestyle Intervention for Type 2 Diabetes: Implications for Diabetes Management (2012) (2)
- 'If I don't work, I don't get paid': An Australian qualitative exploration of the financial impacts of acute myeloid leukaemia. (2021) (2)
- Neonatal vitamin D supplementation (2017) (2)
- Hazelwood Health Study Adult Survey: Volume 2 The relationship between Hazelwood mine fire smoke exposure and health outcomes (2018) (2)
- The Cost of Control: Cost-Effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth. (2022) (2)
- Potential positive effects of bariatric surgery on healthcare resource utilisation (2021) (2)
- Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review (2022) (2)
- Estimating the benefits of obesity prevention on productivity: an Australian perspective (2022) (2)
- Effect of warfarin education on patient knowledge and anticoagulation control: a randomised controlled trial (2018) (2)
- Pharmacoeconomic evaluation of midazolam versus droperidol in the management of acute agitation in the Emergency Department (2012) (1)
- Incidence and Predictors of 30-Day Unplanned Cardiac Readmission Following Percutaneous Coronary Intervention: Insights from the Victorian Cardiac Outcomes Registry (2017) (1)
- Benefits of Family Meetings for Hospitalized Palliative Care Patients and Their Family Caregivers (2018) (1)
- THE INDIGO STUDY: A RANDOMIZED CONTROLLED TRIAL OF PHYSICAL ACTIVITY WITH INDIVIDUAL GOAL-SETTING AND VOLUNTEER MENTORS TO OVERCOME SEDENTARY LIFESTYLE IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE (2014) (1)
- Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia (2022) (1)
- Dynamics of switching, adherence, and persistence of dipeptidyl peptidase-4 inhibitors use: a nationwide cohort study. (2019) (1)
- Sex differences in prehospital analgesia in patients presenting with acute coronary syndromes and their association with clinical outcomes (2022) (1)
- Initial therapy with empagliflozin in addition to metformin vs standard therapy alone for patients with type 2 diabetes mellitus and cardiovascular disease in qatar. A cost-effectiveness analysis (2021) (1)
- Defining optimal care for functional gut disorders - Multi-disciplinary versus standard care: A randomized controlled trial protocol. (2019) (1)
- PCV126 THE CARDIOVASCULAR CONSEQUENCES OF SWITCHING FROM ATORVASTATIN TO GENERIC SIMVASTATIN IN THE NETHERLANDS (2010) (1)
- Reassessing the cost-effectiveness of nivolumab for the treatment of renal cell carcinoma based on mature survival data, updated safety and lower comparator price (2021) (1)
- Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments. (2018) (1)
- DOP086 Intestinal resection in Crohn's disease is associated with significant and durable improvement in health related quality of life although to a lesser extent in women and smokers. Results from the POCER study (2014) (1)
- The COACH Program is Cost-Effective for the Secondary Prevention of Coronary Heart Disease (2010) (1)
- Treatment Gap in Heart Failure with Reduced Ejection Fraction Patients: How Well are we Implementing Evidence-Based Care? (2016) (1)
- PMH2 The IMPACT of Major Depression on Productivity in South Korea (2020) (1)
- Impact of Age and Sex on Treatment and Outcomes Following Myocardial Infarction. (2021) (1)
- CC1 COST-EFFECTIVENESS OF SCREENING AND TREATING CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA EARLY IN LIFE FROM A DUTCH HEALTHCARE PERSPECTIVE (2019) (1)
- A Retrospective Cohort Study of Heart Failure in the Australian Primary Care Setting – Clinical Characteristics of HF Patients (SHAPE Study) (2019) (1)
- Optimal delivery of care for functional gastrointestinal disorders: Randomized controlled trial of standard gastroenterologist-only care versus multidisciplinary care (MANTRA study) (2019) (1)
- INITIATION STUDY: A MODEL OF CARE FOR COMMENCING BASAL/PRANDIAL INSULIN IN T2D IN PRIMARY CARE WITH ADJUNCT RETROSPECTIVE-CONTINUOUS GLUCOSE MONITORING (2014) (1)
- The VINE study: vitamin D in newborns: a randomized controlled trial comparing daily and bolus supplementation in breastfed infants of vitamin D deficient mothers (2015) (1)
- The epidemiological and pathogenic association of rheumatoid arthritis with atherosclerotic cardiovascular disease. (2011) (1)
- The pharmacoeconomics of managing acute agitation in the emergency department: what do we know and how do we approach it? (2012) (1)
- Risk Factors for Incident Heart Failure with Preserved or Reduced Ejection Fraction in a Community-Based Cohort (2018) (1)
- PW177 Literature Review Of The Cost And Cost Effectiveness Of Amlodipine In The Treatment Of Hypertension (2014) (1)
- Effectiveness of a Phone-Based Care Coordination Pilot on Reducing Hospital Utilisation and Costs for Patients with Chest Pain (2016) (1)
- Aetiologies and factors associated with poor clinical outcomes in rhabdomyolysis: a retrospective cohort study in an Australian trauma centre (2021) (1)
- PNS16 Health and Economic Burden of Smoking in Indonesia (2020) (1)
- The 'Four-hour target' (NEAT) and the impact on metropolitan acute urological services (2015) (1)
- PCN59 - Risk Share Agreements (RSA), Product Listing Agreements (PLA) or Patient Access Schemes (PAS) - All the Same or Different? (2016) (1)
- Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry (2018) (1)
- O084 Is A Telephone Support Program For Rural And Remote Heart Failure Patients Cost-Effective? (2014) (1)
- Cost-Effectiveness of Treatment of Women Aged 70 Years and Older with Both Osteopenia and Microstructural Deterioration. (2020) (1)
- MEAN ANNUAL COSTS OF ANTIHYPERTENSIVE MEDICATIONS AMONG PATIENTS WITH, OR AT RISK OF ATHEROTHROMBOSIS-DATA FROM THE REDUCTION OF ATHEROTHROMBOSIS FOR CONTINUED HEATH (REACH) REGISTRY (2009) (1)
- MACHINE LEARNING MODELS SIGNIFICANT IMPROVE OUTCOME PREDICTION AFTER CARDIAC ARREST (2018) (1)
- 409 RANDOMISED TRIAL OF MULTI-DISCIPLINARY VERSUS STANDARD GASTROENTEROLOGIST CARE FOR FUNCTIONAL GASTROINTESTINAL DISORDERS (2020) (1)
- Characterising experiences with acute myeloid leukaemia using an Instagram content analysis (2021) (1)
- Dihydrosphingosine driven enrichment of sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblasts (2021) (1)
- Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective (2017) (1)
- Statin prescribing in Europe: A comparison of differences and potential impact on health outcomes (2012) (1)
- Evaluation of the Effectiveness of a Phone Based Care Coordination Pilot on Hospital Utilisation and Costs for Patients With Chest Pain. (2018) (1)
- Cost burden and cost-effective analysis of the nationwide implementation of the Quality in Acute Stroke Care protocol in Australia (2021) (1)
- Estimating the Productivity Impact of Acute Myeloid Leukemia in Australia Between 2020 and 2029, Using a Novel Work Utility Measure: The Productivity-Adjusted Life Year (PALY). (2021) (1)
- Clozapine-associated myocarditis and cardiomyopathy - It's the heart that is important, not the classification (2009) (1)
- Real World Adherence to and Persistence With Oral Oncolytics in Multiple Myeloma: A Systematic Review and Meta-analysis. (2022) (1)
- IDDF2021-ABS-0126 Exploring the gut microbiota variation in response to vibrio infection (2021) (1)
- How does the onset of physical disability or dementia in older adults affect economic wellbeing and co-payments for health care? the impact of gender (2022) (1)
- Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis (2019) (1)
- The Cost-Effectiveness of Supplemental Carnosine in Type 2 Diabetes (2022) (1)
- Prevalence, Outcomes and Cost Implications of Patients Undergoing Same Day Discharge After Elective Percutaneous Coronary Intervention (PCI) (2019) (1)
- Healthcare utilisation and costing for decompensated chronic liver disease hospitalisations at a Victorian network. (2022) (1)
- Reference ranges of peripheral blood lymphoid subsets by 10-colour flow cytometry based on 69 healthy adults from Australia. (2016) (1)
- Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes (2019) (1)
- Cost-Effectiveness of Transcatheter Aortic Valve Implantation Compared to Surgical Aortic Valve Replacement in the Intermediate Surgical Risk Population (2019) (1)
- Cardiac rehabilitation referral for PCI patients in Victoria, Australia - gender gap is closing but high-risk patients still miss out (2022) (0)
- Personality, psychosocial and socioeconomic factors predict adherence behaviour in cystic fibrosis (CF) adults (2010) (0)
- Abstract WP385: Seasonal, Circaseptan and Diurnal Variations in Stroke Onset, Severity and Costs: Findings from the Royal Melbourne Hospital Stroke Registry 2004-2011 (2013) (0)
- Factors associated with hypertension and its management among older rural Australians. (2020) (0)
- Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis (2023) (0)
- Sa1143 Need for Recurrent Resection and Complex Phenotype Are Associated With a Specific Antibody Signature in Crohn's Disease Patients Undergoing Resection; Smoking Is Not Associated With Prevalent Antibodies; Prognostic and Mechanistic Implications (2015) (0)
- POSC63 Cost-Effectiveness of Non-Statin Lipid-Modifying Agents for Primary and Secondary Prevention of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus: A Systematic Review (2022) (0)
- Symptomatology of multiple sclerosis relapses varies in relation to demographic and clinical factors (2013) (0)
- PHP32 PROBABILISTIC SENSITIVITY ANALYSIS—A NECESSARY EXTRA? (2010) (0)
- Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings From Melbourne Interventional Group Registry. (2019) (0)
- Clinical Outcomes in Older Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndromes. (2020) (0)
- 2065-P: Effects of Obesity on Productivity in the Australian Population: A Life Table Modelling Study (2019) (0)
- Epidemiological modelling of routine use of low-dose asprin in Australia for the primary prevention of coronary heart disease and stroke in those aged 70 years + (2005) (0)
- Trends in Major Bleeding Post Percutaneous Coronary Intervention (PCI) (2021) (0)
- Cost Effectiveness of Aspirin Among Participants with Atherothrombotic Disease in Australian General Practice, Using “Real World” Data from the Australian REACH Registry (2010) (0)
- Incidence, causes and predictors of unplanned hospital readmission after percutaneous coronary intervention (2020) (0)
- The role of dihydrosphingolipids in disease (2018) (0)
- Quality of life and associations with health-related behaviours among older adults with increased cardiovascular risk. (2022) (0)
- Incidence, Predictors and Clinical Outcomes of Stent Thrombosis Following PCI (2019) (0)
- Antihypertensive medication use and breast cancer risk Reply (2017) (0)
- 176 The Cost-Effectiveness of Dapagliflozin for Chronic Heart Failure in Australia (2020) (0)
- P4419The mortality and productivity burden of smoking in Australia (2017) (0)
- Differences in the Weighted Average Daily Doses of Statins in Latin America and Their Potential Impact on Cardiovascular Outcomes (2013) (0)
- Abstract TP384: Recovery Trajectories in Acute Non-fatal Stroke (2013) (0)
- Diastolic heart failure in the elderly (2002) (0)
- Comparison of Fecal In fl ammatory Markers in Crohn ’ s Disease (0)
- Cost-Effectiveness of Rivaroxaban and Aspirin Compared to Aspirin Alone in Patients with Stable Cardiovascular Disease: An Australian Perspective (2018) (0)
- High incidence of vitamin D deficiency in 2 – 17 year olds presenting with fracture to a Melbourne suburban public hospital (2015) (0)
- Characteristics of National and Major Regional Percutaneous Coronary Intervention Registries: A Systematic Review (2018) (0)
- Prior Coronary Artery Bypass Graft Surgery Impacts 30-day Quality of Life after Percutaneous Coronary Intervention: Evidence from the Victorian Cardiac Outcomes Registry (VCOR) (2022) (0)
- Pilot clinical quality registry for dementia in Australia (2018) (0)
- An Audit Of Glucose Lowering Therapies in Patients With Type 2 Diabetes and Hospitalisation for Heart Failure (2019) (0)
- P1-636 DOES MENTOR-SUPPORTED GOAL- SETTING ENHANCE ADHERENCE TO A 6-MONTH PHYSICAL ACTIVITY PROGRAM, IMPROVE PHYSICAL ACTIVITYAND FITNESS FOR INACTIVE OLDERADULTSATRISKOFALZHEIMER’S DISEASE? THE INDIGO TRIAL (2018) (0)
- Hepatology Clinical (2017) (0)
- Challenges in Data Linkage – Experiences from An Upper Gastrointestinal Cancer Data Linkage Study (2020) (0)
- 468 Cost-Effectiveness Analysis of Inclisiran as Add-On Lipid-Lowering Therapy for Patients With Cardiovascular Disease (2020) (0)
- It doesn’t stop at validation: patient reported outcome measures require ongoing and iterative development (2021) (0)
- 259 The Economic Impact of Sudden Cardiac Arrest (2020) (0)
- The hospitalisations for cardiovascular and respiratory conditions, and emergency department presentations and economic burden of bushfires in Australia between 2021 and 2030: A modelling study. (2022) (0)
- PCV62 THE BURDEN OF ACUTE CORONARY SYNDROMES IN AUSTRALIA (2008) (0)
- PMS47 The Health and Economic Consequences of Delay in Starting Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (2012) (0)
- Comparison of peer mentoring versus peer support in a 6‐month home‐based physical activity program for inactive older adults at risk of Alzheimer’s disease: Experiences from the INDIGO trial (2020) (0)
- Healthy research culture is a patient-centred imperative. (2023) (0)
- 841 Impact of Timing of Percutaneous Coronary Intervention on Clinical Outcomes in Non-ST-Elevation Myocardial Infarction (2020) (0)
- Obesity in total hip replacement. (2009) (0)
- AD2 DYNAMICS OF SWITCHING, ADHERENCE, AND PERSISTENCE OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS USE: AN AUSTRALIAN PERSPECTIVE (2019) (0)
- EE352 Projecting the Incidence and Costs of Major Cardiorenal Complications of Type 2 Diabetes with Widespread GLP-1 RA and SGLT2I Use (2022) (0)
- PDB26 Evidence Requirements in Australia for Drug Reimbursement: The Survival of Cost Minimisation Analysis (2012) (0)
- Physical Activity and the Prevention of Fatal Cardiovascular Events in a High-risk Population (2010) (0)
- FKBP51 levels negatively correlate with Depressive symptoms in Chronic Hepatitis C (2020) (0)
- 363 Personality, psychosocial factors and illness effect on adherence behaviour in cystic fibrosis (CF) (2011) (0)
- Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care. (2022) (0)
- Clozapine-induced Myocarditis: Expose of the Facts - a Review of 116 Cases of Suspected Myocarditis Associated with the Use of Clozapine in Australia 1993-2003 (2006) (0)
- Abstract 20160: The Impact of Obesity on Productivity (2017) (0)
- A Retrospective Cohort Study of Heart Failure in the Australian Primary Care Setting – Method and Demographic Results (SHAPE study) (2019) (0)
- [114-POS] : Are reduced first trimester PAPP-A concentrations in women with Type 1 diabetes associated with preeclampsia, premature delivery, and small for gestational age infants? (2015) (0)
- PCV123 THE CARDIOVASCULAR PREVENTION MODEL (CPM), A GENERICALLY APPLICABLE MODEL FOR UNDERTAKING COST-EFFECTIVENESS ANALYSES OF PREVENTIVE INTERVENTIONS (2008) (0)
- PCV75 Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data from the REACH Registry (2011) (0)
- COX-2 inhibitors and the risk for hypertension (2005) (0)
- Comparison of Traditional and Recent Classification Systems in the Grading of Diastolic Function in Asymptomatic Older Subjects (2012) (0)
- An Economic Evaluation of a Familial Cancer Risk Management Program for Brca Mutation Carriers: An Australian Perspective (2018) (0)
- PDB101 PATTERNS OF ADHERENCE, PERSISTENCE, AND SWITCHING AMONG AUSTRALIANS PRESCRIBED DIPEPTIDYL PEPTIDASE-4 INHIBITORS (2019) (0)
- PCV115 ASSESSING THE POTENTIAL BENEFITS OF CHANGING REIMBURSEMENT CRITERIA FOR LIPID LOWERINGTHERAPY IN KOREA (2008) (0)
- Establishment of a Data Linkage Process Between the Victorian Cardiac Outcomes Registry and Victorian Hospital Admission and Emergency Presentation Administrative Datasets (2018) (0)
- Cases And Meaning of Multiple Criteria Decision Analyses In The Real World: Overview Real Cases And Speculations For Korean Settings (2016) (0)
- Lost therapeutic benefit of delayed LDL-C control in statin treated patients and cost-effectiveness analysis of lipid-lowering intensification. (2022) (0)
- P8 New Onset Cardiovascular Disease in Australia by Socioeconomic Groups: A Modelling Study (2022) (0)
- Comparative cost-effectiveness analyses of thiazide diuretics, betablockers, calcium channel blockers and antagonists of the renin angiotensin system for the primary prevention of cardiovascular disease (2004) (0)
- STEMI Management in a Regional Victorian Centre: 90 Day Outcomes (2009) (0)
- Management of chronic heart failure in the elderly patient (2001) (0)
- POSB167 Cost-Effectiveness of Tobacco Control Strategies in Indonesia (2022) (0)
- Registry-Based Monitoring of Hospital Performance Can Improve Time Delays in Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: A Quality Initiative From the Victorian Cardiac Outcomes Registry (2018) (0)
- Should we continue to subsidise therapeutics with uncertain efficacy? Health economic implications for icosapent ethyl. (2022) (0)
- Association between adequacy of long chain omega-3 intake and N-terminal pro brain natriuretic peptide (NT-proBNP) in those at risk of heart failure (2015) (0)
- Sex Differences in Pre-hospital Analgesia and Outcomes in Patients Presenting with Acute Coronary Syndromes (2021) (0)
- Hypertension with left ventricular dysfunction (2002) (0)
- HOSPITALISED OLDER PEOPLE WITH DEMENTIA AND DELIRIUM: MORE READMISSIONS AND IN-HOSPITAL COMPLICATIONS, GREATER LENGTH OF STAY AND ASSOCIATED HEALTHCARE COSTS (2016) (0)
- Novel behaviour change frameworks for digital health interventions: A critical review. (2023) (0)
- PCV12 Differences in the Weighted Average Daily Doses of Statins in Europe and Their Potential Impact on Cardiovascular Outcomes (2011) (0)
- Predictors of Outcomes After Percutaneous Coronary Intervention in Older Patients Presenting With Non-ST-Elevation Acute Coronary Syndromes: Insights From the VCOR Registry (2018) (0)
- The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease : best case scenario analysis using a Markov model OPEN ACCESS (2012) (0)
- Economic evaluation of pharmaceuticals (2019) (0)
- Renal Safety of a Short Course of Gentamicin in Elderly Patients (the Regent Study) (2017) (0)
- Cost-effectiveness of empagliflozin plus metformin vs metformin alone as first-line therapy in patients with type 2 diabetes mellitus: An australian perspective (2021) (0)
- CHANGES IN PHYSICAL ACTIVITY, GOAL-SETTING SATISFACTION AND PERFORMANCE WITH A SIX-MONTH, HOME-BASED, PHYSICAL ACTIVITY PROGRAM IN INACTIVE OLDER ADULTS AT RISK OF ALZHEIMER’S DISEASE: THE INDIGO TRIAL (2018) (0)
- 725 Cost Effectiveness of Bempedoic Acid for Those at High Risk Cardiovascular Disease (2020) (0)
- Sex-Specific Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease: A Systematic Review and Meta-Analysis (2022) (0)
- EXPLORING THE GUT MICROBIOTA VARIATION IN RESPONSE (2021) (0)
- 1594-P: The Impact of Diabetes on Productivity in China (2019) (0)
- HPR35 The Impact of Biosimilar Trastuzumab on Drug Spending in Australia (2022) (0)
- PCV47 DOES THE COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN COMBINATION WITH STATIN THERAPY COMPARED TO STATIN ALONE DIFFER BETWEEN PRIMARY AND SECONDARY PREVENTION? (2019) (0)
- P2814 Serum brain natriuretic peptide for screening of left-ventricular abnormalities in people with impaired glucose tolerance and diabetes mellitus (2003) (0)
- PCV76 THE KOREAN INDIVIDUAL-MICROSIMULATION MODEL FOR CARDIOVASCULAR HEALTH INTERVENTIONS (KIMCHI) (2008) (0)
- Abstract 6236: Potential Survival Gains in the Treatment of Myocardial Infarction in Australia (2008) (0)
- Early vs. Late Readmission following Percutaneous Coronary Intervention: Predictors and Impact on Long-Term Outcomes (2023) (0)
- Cost‐analysis of opportunistic influenza vaccination in general medical inpatients (2021) (0)
- Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031 (2023) (0)
- EPH51 The Health and Economic Burden of Bushfires in Australia Between 2021 and 2030: A Modelling Study (2022) (0)
- Dietary micronutrient intake and cardiovascular risk factors in a population at risk of heart failure (2014) (0)
- PIH22 ESTIMATING THE PRODUCTIVITY BURDEN OF PEDIATRIC PNEUMOCOCCAL DISEASE IN THAILAND (2019) (0)
- PCV65 Service Utilization, Predictors and Costs among High-Risk Patients with Cardiovascular Disease: Using Real World Data from the Australian Reach Registry (2012) (0)
- Impact of Limited English Proficiency on Ischaemic Time and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction (2019) (0)
- Cost Utility Of Diabetes Drugs Using Hba1c As A Direct Predictor For Quality Of Life, Diabetes Complications And Mortality. (2014) (0)
- 170-LB: Efficacy and Safety of Technology in Type 1 Diabetes: A Systematic Review and Network Meta-analysis (2019) (0)
- IMPROVEMENTS IN SUBTHRESHOLD ANXIETY AND DEPRESSION SYMPTOMS IN OLDER, SEDENTARY ADULTS AT RISK OF ALZHEIMER’S DISEASE WHO ENGAGE IN A PHYSICAL ACTIVITY INTERVENTION (2018) (0)
- Monash Clinical Registries Portfolio 2017 (2016) (0)
- Left Atrial Phasic Function Predicts NT-proBNP in Asymptomatic Community Patients at Risk for Heart Failure (2021) (0)
- Redundancy in meta‐analyses publications—Time to pull the plug (2021) (0)
- Urinary incontinence in community dwelling Australian adults aged 70 years and above: Prevalence and causal associations (2020) (0)
- Longer-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention (2019) (0)
- Mo1825 Examination of the Relationship Between Disease Activity, and Psychological Distress and Patient Reported Outcome Measures in an IBD Cohort (2016) (0)
- Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis (2008) (0)
- PMC4 CHOOSING THE RIGHT DISTRIBUTION WHEN PERFORMING PROBABILISTIC SENSITIVITY ANALYSIS: RELATIVE RISKS AND THE TRIANGULAR DISTRIBUTION A SIMULATION STUDY (2010) (0)
- The Impact of Severe Hip and Knee Joint Disease On Paid and Unpaid Work Participation in Australia (2012) (0)
- CV1 Statin Prescription in Australia: A Comparison of Differences in Prescribed Doses and Potential Impact on Health Outcomes (2012) (0)
- PCV81 ECONOMIC IMPLICATIONS OF OBESITY AMONG PEOPLE WITH ATHEROTHROMBOTIC DISEASE IN AUSTRALIA (2009) (0)
- EE217 Lost Therapeutic Benefit of Delayed LDL-C Control and Cost-Effectiveness Analysis of Lipid-Lowering Intensification (2022) (0)
- PND15 The Health and Productivity Burden of Migraines in Australia (2020) (0)
- EPH79 Projections of Future Health and Economic Burden of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus in Australia. Estimates up to 2030 (2022) (0)
- High incidence of vitamin D deficiency in 2 – 17 year olds presenting with fracture to a Melbourne suburban public hospital (2015) (0)
- 733 WITHDRAWN:Â Health Economic Evaluation of Screening and Treating Children With Familial Hypercholesterolemia Early in Life: Many Happy Returns on Investment? (2020) (0)
- Cost-Effectiveness of Cyp2c19*2 Genotype Guided Selection of Clopidogrel or Ticagrelor in Hong Kong Chinese Patients with Acute Coronary Syndrome (2016) (0)
- 471 MOST INDIVIDUALS WITH TREATED BLOOD PRESSURES ABOVE TARGET RECEIVE ONLY ONE OR TWO ANTIHYPERTENSIVE DRUG CLASSES: CROSS-SECTIONAL STUDY OF AUSTRALIANS AT INCREASED CARDIOVASCULAR RISK (2012) (0)
- Burden of Permanent Pacemaker Implantation Post Aortic Valve Replacement in Australia (2021) (0)
- Abstract P264: The Health and Economic Impact of Switching From Atorvastatin to Generic Simvastatin in the Netherlands (2011) (0)
- Abstract 20184: Impact of Smoking on Population Health and Productivity (2017) (0)
- Population Genomic Screening of Young Adults for Familial Hypercholesterolaemia: A Cost-Effectiveness Analysis (2022) (0)
- Vascular Responses Among Adults Four Years Post Exposure to 6 Weeks of Smoke from the Hazelwood Coal Mine Fire (2022) (0)
- PCV51 SINGLE PILL AMLODIPINE/ATORVASTATIN IS COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN KOREA (2008) (0)
- Comparative cost-effectiveness of interventions for the primary prevention of coronary heart disease (2002) (0)
- Adherence behaviour of adult cystic fibrosis (CF) patients to prescribed azithromycin (2010) (0)
- POSC32 Attainment of Low-Density Lipoprotein Cholesterol Targets in Statin Treated Patients: Real-World Evidence from Australian Primary Care (2022) (0)
- PCV72 ESTIMATING LIFETIME ECONOMIC BURDEN OF STROKE IN KOREA ACCORDING TO THE AGE OF ONSET: USING NATIONAL HEALTH INSURANCE CLAIMS DATABASE (2009) (0)
- Adenoidectomy and tonsillectomy in Victoria, Australia – data to support state-wide service improvement (2017) (0)
- Epidemiological modelling of routine use of low-dose aspirin for the primary prevention of cardiovascular disease in those aged 70 years (2003) (0)
- Mo1824 Health Care Costs Associated With Standard Inflammatory Bowel Disease Care in Australia and Opportunities to Improve Care: A Tertiary Center Study (2016) (0)
- Des-1 Inhibition Attenuated Cardiac Remodelling in a Mouse Model of Ischaemia Reperfusion (2021) (0)
- PCV6 EFFECTIVENESS OF CLOPIDOGREL IN ADDITION TO ASPIRIN COMPARED TO ASPIRIN ALONE AFTER ACUTE CORONARY SYNDROME (2008) (0)
- 838 Impact of Age and Sex on Treatment and Outcomes Following Percutaneous Coronary Intervention for Myocardial Infarction (2020) (0)
- Medication Communication During Handovers Involving Nurses in Speciality Hospital Settings (2014) (0)
- Productivity burden borne by the parents of persons with Angelman syndrome (2021) (0)
- Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study (2018) (0)
- PCV94 Dronedarone is Cost-Effective for the Prevention of Downstream Cardiovascular Morbidity and Mortality in Australian Patients with Atrial Fibrillation (2011) (0)
- EE262 An Economic Evaluation and Return on Investment of the Community Benefit of the Australian Pregnancy Register of Anti-Seizure Medications (2022) (0)
- PCV92 THE HEALTH AND ECONOMIC IMPACT OF SWITCHING FROM ATORVASTATIN TO SIMVASTATIN IN THE US (2008) (0)
- Cost-effectiveness modelling of low-dose aspirin for the primary prevention of cardiovascular disease (2004) (0)
- An economic evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry programme-subanalyses for Māori (ANZACS-QI 42). (2020) (0)
- CV1 USING REAL WORLD DATA TO CALCULATE THE COST-EFFECTIVENESS OF STATIN AMONG PARTICIPNATS WITH ATHEROTHROMBOTIC DISEASE IN AUSTRALIAN GENERAL PRACTICE (2010) (0)
- 757 The Productivity Impact of Coronary Heart Disease Prevention in Australia Over Ten Years (2020) (0)
- Protocol Patterns and Predictors of Adherence to Statin Therapy Among Older Patients : Protocol for a Systematic Review (2017) (0)
- 314 Cost-Effectiveness of Systematic Coronary Artery Calcium Scans Compared with Risk Scoring under Current Australian and US Guidelines (2020) (0)
- Evaluation of the Pain Impact Index for Community‐Dwelling Older Adults Through the Application of Rasch Modelling (2020) (0)
- [117-POS]: Neonatal outcomes in babies of mother with type 1 diabetes with and without preeclampsia (2015) (0)
- Abstract P100: The Cardiovascular Consequences of Switching From Atorvastatin to Generic Simvastatin in the Netherlands (2011) (0)
- Hazelwood Health Study Annual Report 4 (2016) (0)
- Structural Heart Disease is Common Within a Community Cohort at Risk of Heart Failure—The SCREEN-HF Study (2013) (0)
- PCV82 THE IMPACT OF LOST THERAPEUTIC BENEFIT (LTB) IN HIGH RISK PATIENTS MANAGED FOR HYPERTENSION IN AUSTRALIAN GENERAL PRACTICE (2009) (0)
- Retrospective clinical audit of high risk medication use in an emergency department of a public teaching hospital (2012) (0)
- DOES MENTOR-SUPPORTED GOAL-SETTING ENHANCE ADHERENCE TO A 6-MONTH PHYSICAL ACTIVITY PROGRAM, IMPROVE PHYSICAL ACTIVITY AND FITNESS FOR INACTIVE OLDER ADULTS AT RISK OF ALZHEIMER’S DISEASE? THE INDIGO TRIAL (2018) (0)
- Clinical risk stratification accurately predicts development of endoscopic recurrence after Crohn (2012) (0)
- Number Needed to Treat and Cost Per Responder of Janus Kinase Inhibitors Approved for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Japan. (2022) (0)
- PCN97 Comparison of Disease-Specific (QLU-C10D) and Generic (EQ-5D) Utilities in Cost-Effectiveness Analysis (2020) (0)
- Current Issues in Health Technology Assessment of Cancer Therapies: A Survey of Stakeholders and Opinion Leaders in Australia (2022) (0)
- Correction: Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis (2019) (0)
- Cost Effectiveness Of Apixaban Comapred To Aspirin In Patients With Atrial Fibrillation (2014) (0)
- Outcomes of community and prison-based hepatitis C treatment using an eHealth model of care (2020) (0)
- Author's response to reviews Title:An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION STUDY PROTOCOL Authors: (2014) (0)
- LivR Well: a feasibility study for a home-based, multidisciplinary liver optimization program for the first 28 days after an admission for acute-on-chronic liver failure (2022) (0)
- Author response: Excess mortality and hospitalized morbidity in newly treated epilepsy patients (2017) (0)
- Artificial intelligence for secondary prevention of myocardial infarction: A qualitative study of patient and health professional perspectives (2023) (0)
- A14636 Dispensing patterns of blood pressure lowering agents in elderly Australians (65 years and above) from 2006 to 2016 (2018) (0)
- Cost-Effectiveness Analysis of Tobacco Control Strategies in Indonesia. (2022) (0)
- Which strategies support the effective use of clinical practice guidelines and clinical quality registry data to inform health service delivery? A systematic review (2022) (0)
- A pilot Dementia Clinical Quality Registry to improve dementia clinical care (2018) (0)
- Prospective multisite cohort study of patient‐reported outcomes in adults with new‐onset seizures (2021) (0)
- Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis (2022) (0)
- O016 Exploring the drivers of geographic variation for paediatric tonsillectomy and adenoidectomy (2021) (0)
- P2643Risk-adjusting key outcome measures in a clinical quality registry of PCI: development of a highly predictive model without the need to exclude very high risk conditions (2018) (0)
- Early transthoracic echocardiography has useful prognostic value in left-sided native valve endocarditis despite limited diagnostic performance (2019) (0)
- Clinical variation in the use of echocardiography in Staphylococcus aureus bacteraemia: a multi-centre cohort study (2018) (0)
- The impact of coronary heart disease on productivity in Australia over ten years (2020) (0)
- PCV70 COST-EFFECTIVENESS OF CLOPIDOGREL IN COMBINATION WITH ASPIRIN FOR ACUTE CORONARY SYNDROMES IN AUSTRALIA (2008) (0)
- Economic impact of sudden cardiac arrest (2020) (0)
- Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review (2018) (0)
- Estimating the impact of Angelman syndrome on parental productivity in Australia using productivity-adjusted life years. (2022) (0)
- 535 Prescribing Patterns of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention for Acute Coronary Syndromes from the Victorian Cardiac Outcomes Registry (2020) (0)
- Does Down Syndrome influence the outcomes of congenital cardiac surgery? A systematic review and meta-analysis. (2022) (0)
- Immuno-oncology therapies: a looming mid-life crisis? (2022) (0)
- 469 Cost-Effectiveness of Radial Access Percutaneous Coronary Intervention in Acute Coronary Syndrome (2020) (0)
- Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary intervention (2022) (0)
- Long-Term Outcomes of Contemporary Percutaneous Coronary Intervention with the Xience Drug-Eluting Stent: Results from a Multicentre Australian Registry (2020) (0)
- Estimating the economic impact of acute coronary syndrome in New Zealand over time (ANZACS-QI 64): a national registry-based cost burden study (2022) (0)
- Academic health science centre models across the developing countries and lessons for implementation in Indonesia: a scoping review (2022) (0)
- ASSOCIATION BETWEEN USE OF STATINS AND OUTCOMES IN HEART FAILURE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2017) (0)
- PCN89 Constructing Comparator Survival DATA: Simulated Versus Individual Patient DATA (2020) (0)
- Cost and economic determinants of paediatric tonsillectomy. (2022) (0)
- P2654Impact of cultural and linguistic diversity on ischaemic time and clinical outcomes in patients undergoing percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) (2019) (0)
- Impact of prehospital opioid dose on angiographic and clinical outcomes in acute coronary syndromes (2022) (0)
- Author reply (2013) (0)
- Bringing researchers and communities together to develop a pilot dementia registry in Victoria (2018) (0)
- PCV62 ECONOMIC EVALUATION AND NETWORK META-ANALYSIS OF NON-STATIN THERAPY AMONG STATIN-TREATED PATIENTS IN THAILAND (2019) (0)
- Cost-effectiveness of screening BNP-levels in patients at-risk of asymptomatic left ventricular dysfunction (2008) (0)
- More or less physical activity and the effect on cardiovascular mortality in a high-risk population (2011) (0)
- Tu1289 Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels (2015) (0)
- Relationship Between Amino-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) and Left Atrial Volume Index in Older Subjects at Risk of Heart Failure (2011) (0)
- What causes post-operative Crohn's disease recurrence? Evaluation of gut microbiota, anti-TNF non-response and smoking (2015) (0)
- Improved Long-term Survival in Patients on Combination Therapies Following Acute Myocardial Infarction: A Longitudinal Population-based Study (2013) (0)
- Recovery Trajectories in Acute Non-fatal Stroke (2013) (0)
- Title-The “ cost ” of treating to target : Cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian General Practice (2012) (0)
- PMS8 COST-EFFECTIVENESS OF RISEDRONATE FOR CORTICOSTEROID INDUCED OSTEOPOROSIS IN AUSTRALIA (2010) (0)
- Relapse incidence in women and men throughout the course of multiple sclerosis: An MSBase cohort study (2013) (0)
- 743 WITHDRAWN:Â Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness. (2020) (0)
- DB3 Indirect Treatment Comparison (ITC) or Cost-Effectiveness Analysis (CEA): a Study (2012) (0)
- PCV92 THE HEALTH AND ECONOMIC IMPACT OF SWITCHING FROM ATORVASTATIN TO GENERIC SIMVASTATIN IN BELGIUM (2010) (0)
- Has the implementation of time-based-targets for emergency department length-of-stay influenced the quality of care for patients? A systematic review of qualitative literature (2021) (0)
- 315 ASSOCIATION OF LOW DIASTOLIC BLOOD PRESSURE WITH INCREASED AMINO-TERMINAL-PRO-B-TYPE NATRIURETIC PEPTIDE LEVELS EXPLAINED BY COMORBIDITIES THAT INCREASE HEART FAILURE RISK: CROSS-SECTIONAL STUDY OF AUSTRALIANS AT INCREASED CARDIOVASCULAR RISK (2012) (0)
- Heart failure with preserved ejection fraction (HFpEF) is the predominant cause of incident chronic heart failure in contemporary Australia (2016) (0)
- Erratum to ‘Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system’ [Leukemia Research 112C (2022) 106748] (2022) (0)
- PSA doubling time as a screening test to predict bone scan positivity (2015) (0)
- Implications of Price Erosion of Docetaxel After Loss of Exclusivity on Cost-Effectivess (2016) (0)
- 282-OR: The Association of Age of Onset of Type 2 Diabetes with Long-Term Risk of End Stage Kidney Disease: A National Registry Study (2020) (0)
- In reply: Epidemiological modelling (including economic modelling) and its role in preventive drug therapy (2003) (0)
- Cost Utility Analysis (CUA) of Nivolumab Compared To Everolimus for The Treatment of Metastatic Renal Cell Carcinoma (RCC) in Australia (2017) (0)
- Abstract 3671: Blood Pressure is Inadequately Treated in Australia Especially Among Males and Those Under Sixty Five Years (2007) (0)
- Abstract 14593: TemporalTrends of Heart Failure Patients Undergoing Percutaneous Coronary Intervention: Findings From Melbourne Interventional Group Registry (2017) (0)
- Economic Evaluation of the Community Benefit of the Australian Pregnancy Register of Antiseizure Medications (2022) (0)
- 517Challenges in data linkage – experiences from an upper gastrointestinal cancer data linkage study (2021) (0)
- Incidence, Predictors and Outcomes of Failed Percutaneous Coronary Intervention in Contemporary Australian Practice (2019) (0)
- Trends and Predictors of Cardiac Rehabilitation Referral Following Percutaneous Coronary Intervention: A Prospective, Multi-Site Study of 41,739 Patients From the Victorian Cardiac Outcomes Registry (2017-2020). (2022) (0)
- Recent advances in the management of chronic heart failure. (2003) (0)
- Healthcare services use by patients with heart failure in Australia: Findings from the SHAPE study. (2022) (0)
- Statin prescription in Europe: the potential conflict between clinical guidelines and healthcare policies (2012) (0)
- 102-LB: GP-OSMOTIC: An RCT to Determine the Effect of 3-Monthly Retrospective Continuous Glucose Monitoring (rCGM) on 12-Month HbA1c in Adults with Type 2 Diabetes (T2D) in Primary Care (2019) (0)
This paper list is powered by the following services:
Other Resources About Danny Liew
What Schools Are Affiliated With Danny Liew?
Danny Liew is affiliated with the following schools:
